PRAC cautions use of Lemtrada, Xeljanz in latest meeting

1st November 2019 Uncategorised 0

Pfizer’s Xeljanz could potentially increase the risk of blood clots.

More: PRAC cautions use of Lemtrada, Xeljanz in latest meeting
Source: News